SPIRONOLACTONE

SPIRONOLACTONE was reported 142743 times

SPIRONOLACTONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EJECTION FRACTION 225 0.3873
1 SENSITISATION 257 0.3386
2 POLYCYSTIC OVARIES 283 0.1823
3 DEVICE MAINTENANCE ISSUE 104 0.1769
4 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 247 0.1758
5 HYPERKALAEMIA 5096 0.1452
6 CARDIOACTIVE DRUG LEVEL INCREASED 190 0.1445
7 CARDIAC FAILURE CHRONIC 599 0.1404
8 SPUTUM CULTURE POSITIVE 114 0.1404
9 BRASH SYNDROME 193 0.1375
10 EJECTION FRACTION ABNORMAL 157 0.1281
11 ORTHOPNOEA 387 0.1214
12 RIGHT VENTRICULAR FAILURE 796 0.1135
13 BRAIN NATRIURETIC PEPTIDE INCREASED 349 0.1131
14 HEPATIC ENCEPHALOPATHY 1044 0.1118
15 HEPATORENAL SYNDROME 175 0.1036
16 ISCHAEMIC CARDIOMYOPATHY 300 0.0978
17 ACUTE PRERENAL FAILURE 104 0.0898
18 OESOPHAGEAL VARICES HAEMORRHAGE 194 0.0893
19 PRODUCT MONITORING ERROR 123 0.0851
20 LEFT ATRIAL DILATATION 108 0.0846
21 VARICES OESOPHAGEAL 254 0.0839
22 PULMONARY ARTERIAL PRESSURE INCREASED 136 0.0834
23 INFUSION SITE DISCHARGE 145 0.0826
24 OBSTRUCTIVE SLEEP APNOEA SYNDROME 119 0.0816
25 CONGESTIVE CARDIOMYOPATHY 340 0.0815
26 BRONCHIAL SECRETION RETENTION 102 0.0801
27 ATRIAL TACHYCARDIA 165 0.0785
28 NEPHROGENIC ANAEMIA 356 0.0768
29 HEPATIC NEOPLASM MALIGNANT 159 0.0750
30 RHINITIS ALLERGIC 332 0.0745
31 BUNDLE BRANCH BLOCK LEFT 306 0.0721
32 PULMONARY ARTERIAL HYPERTENSION 1035 0.0714
33 AMMONIA INCREASED 364 0.0713
34 HYPERPARATHYROIDISM SECONDARY 177 0.0706
35 INFUSION SITE HAEMORRHAGE 231 0.0701
36 HYPERVOLAEMIA 346 0.0699
37 INFUSION SITE INFECTION 159 0.0684
38 CARDIAC FAILURE ACUTE 453 0.0679
39 PULMONARY HYPERTENSION 1385 0.0664
40 LEFT VENTRICULAR FAILURE 228 0.0662
41 ASCITES 1912 0.0650
42 METABOLIC ALKALOSIS 102 0.0636
43 BLOOD POTASSIUM INCREASED 1014 0.0624
44 TRICUSPID VALVE INCOMPETENCE 496 0.0624
45 DEVICE INFUSION ISSUE 154 0.0620
46 BRADYARRHYTHMIA 101 0.0614
47 HYPOVOLAEMIA 354 0.0604
48 ESSENTIAL HYPERTENSION 110 0.0600
49 MITRAL VALVE INCOMPETENCE 678 0.0598
50 SYSTEMIC INFECTION 99 0.0597
51 THERAPEUTIC AGENT TOXICITY 199 0.0596
52 PORTAL HYPERTENSION 183 0.0593
53 VENTRICULAR HYPOKINESIA 189 0.0588
54 SINUS NODE DYSFUNCTION 107 0.0584
55 LEFT VENTRICULAR DYSFUNCTION 389 0.0580
56 CARDIAC FAILURE 4657 0.0580
57 CATHETER SITE ERYTHEMA 123 0.0574
58 CARDIOMEGALY 677 0.0550
59 INFUSION SITE PAIN 705 0.0547
60 EJECTION FRACTION DECREASED 845 0.0543
61 HEPATIC CIRRHOSIS 1001 0.0532
62 BLOOD UREA INCREASED 889 0.0530
63 DIASTOLIC DYSFUNCTION 163 0.0528
64 ATRIOVENTRICULAR BLOCK COMPLETE 353 0.0527
65 OXYGEN CONSUMPTION INCREASED 125 0.0523
66 INFUSION SITE ERYTHEMA 441 0.0523
67 HYPONATRAEMIA 2921 0.0518
68 DYSPNOEA AT REST 149 0.0514
69 VENTRICULAR TACHYCARDIA 837 0.0506
70 LEFT VENTRICULAR HYPERTROPHY 215 0.0502
71 NIPPLE PAIN 102 0.0500
72 HAEMORRHAGIC ANAEMIA 220 0.0500
73 ATRIOVENTRICULAR BLOCK FIRST DEGREE 213 0.0491
74 DILATATION VENTRICULAR 103 0.0490
75 HAEMOGLOBIN INCREASED 218 0.0477
76 REBOUND ACID HYPERSECRETION 144 0.0476
77 AORTIC VALVE INCOMPETENCE 202 0.0474
78 RENAL FAILURE ACUTE 2006 0.0472
79 ACUTE KIDNEY INJURY 7153 0.0467
80 RALES 267 0.0459
81 CATHETER SITE HAEMORRHAGE 115 0.0459
82 INFUSION SITE SWELLING 284 0.0451
83 GLOMERULAR FILTRATION RATE DECREASED 550 0.0447
84 ATRIAL FLUTTER 351 0.0439
85 BLOOD PRESSURE SYSTOLIC DECREASED 199 0.0437
86 BLOOD POTASSIUM ABNORMAL 115 0.0431
87 VASCULAR DEVICE INFECTION 193 0.0425
88 CATHETER SITE PAIN 110 0.0424
89 INTERNATIONAL NORMALISED RATIO INCREASED 1204 0.0422
90 CREPITATIONS 124 0.0416
91 FLUID RETENTION 2114 0.0415
92 CARDIOMYOPATHY 612 0.0414
93 DYSPNOEA EXERTIONAL 1559 0.0413
94 ORTHOSTATIC HYPOTENSION 712 0.0408
95 ATRIOVENTRICULAR BLOCK 315 0.0407
96 CONCOMITANT DISEASE AGGRAVATED 251 0.0406
97 CARDIAC DYSFUNCTION 151 0.0405
98 PROTHROMBIN TIME PROLONGED 241 0.0403
99 AORTIC STENOSIS 140 0.0402
100 BREATH SOUNDS ABNORMAL 194 0.0393
101 OLIGURIA 244 0.0393
102 INFUSION SITE PRURITUS 124 0.0393
103 FLUID OVERLOAD 572 0.0393
104 BLOOD CHLORIDE DECREASED 101 0.0391
105 CARDIAC FAILURE CONGESTIVE 3137 0.0390
106 INFUSION SITE REACTION 116 0.0388
107 BUNDLE BRANCH BLOCK RIGHT 178 0.0387
108 CARDIOGENIC SHOCK 555 0.0386
109 ACUTE PULMONARY OEDEMA 214 0.0381
110 SLEEP APNOEA SYNDROME 721 0.0377
111 ELECTROLYTE IMBALANCE 437 0.0376
112 IRON DEFICIENCY ANAEMIA 337 0.0365
113 CREATININE RENAL CLEARANCE DECREASED 146 0.0364
114 HYPERURICAEMIA 149 0.0362
115 ANGINA UNSTABLE 230 0.0354
116 HYPOKALAEMIA 1624 0.0351
117 HYPOVOLAEMIC SHOCK 168 0.0350
118 CATHETERISATION CARDIAC 154 0.0347
119 BLOOD SODIUM DECREASED 654 0.0347
120 HYPERCAPNIA 104 0.0345
121 CARDIAC MURMUR 298 0.0344
122 GENERALISED OEDEMA 426 0.0344
123 CATHETER SITE INFECTION 130 0.0343
124 URINE OUTPUT DECREASED 300 0.0343
125 BLOOD URIC ACID INCREASED 197 0.0341
126 BLOOD CREATINE INCREASED 151 0.0341
127 PORTAL VEIN THROMBOSIS 109 0.0337
128 ELECTROCARDIOGRAM ABNORMAL 264 0.0336
129 POLYURIA 274 0.0334
130 OEDEMA 1808 0.0333
131 VENTRICULAR FIBRILLATION 370 0.0333
132 BRADYCARDIA 1762 0.0332
133 HEPATIC FAILURE 987 0.0327
134 MELAENA 718 0.0326
135 AZOTAEMIA 130 0.0325
136 EXERCISE TOLERANCE DECREASED 187 0.0325
137 BLOOD CREATININE INCREASED 2119 0.0324
138 RENAL FAILURE CHRONIC 248 0.0322
139 DIZZINESS POSTURAL 312 0.0321
140 PULMONARY CONGESTION 423 0.0321
141 INTERNATIONAL NORMALISED RATIO DECREASED 129 0.0318
142 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 281 0.0318
143 HYPOALBUMINAEMIA 247 0.0317
144 OEDEMA PERIPHERAL 3870 0.0317
145 SUPRAVENTRICULAR EXTRASYSTOLES 107 0.0316
146 UPPER GASTROINTESTINAL HAEMORRHAGE 532 0.0316
147 CHRONIC KIDNEY DISEASE 2401 0.0316
148 SHOCK HAEMORRHAGIC 257 0.0315
149 LOCALISED OEDEMA 146 0.0315
150 END STAGE RENAL DISEASE 573 0.0314
151 BLOOD POTASSIUM DECREASED 944 0.0314
152 CARDIAC VALVE DISEASE 178 0.0311
153 VENTRICULAR EXTRASYSTOLES 320 0.0308
154 HYPOTENSION 6175 0.0308
155 RENAL IMPAIRMENT 2571 0.0306
156 SINUS BRADYCARDIA 295 0.0305
157 GASTRITIS EROSIVE 139 0.0298
158 PEMPHIGOID 225 0.0298
159 ANURIA 256 0.0297
160 ATRIAL FIBRILLATION 2879 0.0295
161 PERICARDIAL EFFUSION 683 0.0295
162 SEASONAL ALLERGY 418 0.0295
163 CARPAL TUNNEL SYNDROME 413 0.0295
164 ACUTE RESPIRATORY FAILURE 567 0.0294
165 LOWER GASTROINTESTINAL HAEMORRHAGE 216 0.0292
166 CAROTID ARTERY OCCLUSION 106 0.0290
167 BLOOD ALBUMIN DECREASED 229 0.0288
168 PULMONARY OEDEMA 1274 0.0284
169 DERMATITIS CONTACT 324 0.0284
170 HYPERNATRAEMIA 139 0.0279
171 RENAL FAILURE 3704 0.0279
172 EMBOLIC STROKE 98 0.0278
173 ACIDOSIS 212 0.0277
174 HAEMORRHOIDAL HAEMORRHAGE 135 0.0276
175 BLOOD TEST ABNORMAL 388 0.0276
176 HEPATOCELLULAR CARCINOMA 210 0.0276
177 HYPERLIPIDAEMIA 328 0.0274
178 UPPER-AIRWAY COUGH SYNDROME 226 0.0274
179 BLOOD PRESSURE DIASTOLIC DECREASED 202 0.0273
180 VENTRICULAR ARRHYTHMIA 100 0.0273
181 TORSADE DE POINTES 214 0.0273
182 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 280 0.0272
183 RED CELL DISTRIBUTION WIDTH INCREASED 113 0.0272
184 TROPONIN INCREASED 206 0.0270
185 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 137 0.0270
186 HEPATOMEGALY 265 0.0269
187 TRANSFUSION 282 0.0269
188 PAIN IN JAW 760 0.0268
189 BLOOD PRESSURE DECREASED 1777 0.0267
190 GOUT 473 0.0263
191 PLEURAL EFFUSION 1594 0.0262
192 DEHYDRATION 3487 0.0261
193 SUBARACHNOID HAEMORRHAGE 266 0.0261
194 BLOOD BILIRUBIN INCREASED 702 0.0260
195 ATELECTASIS 250 0.0258
196 OXYGEN SATURATION DECREASED 1450 0.0258
197 PRODUCT ADMINISTRATION INTERRUPTED 202 0.0257
198 WEIGHT FLUCTUATION 269 0.0257
199 DRUG INTERACTION 4071 0.0256
200 MULTIPLE ALLERGIES 201 0.0256
201 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 131 0.0255
202 PURULENT DISCHARGE 109 0.0255
203 ARTERIOSCLEROSIS CORONARY ARTERY 168 0.0253
204 ENDOCARDITIS 130 0.0253
205 OBSTRUCTIVE AIRWAYS DISORDER 281 0.0252
206 DYSLIPIDAEMIA 128 0.0252
207 PURPURA 221 0.0250
208 GOITRE 102 0.0249
209 DIABETIC NEUROPATHY 123 0.0248
210 BLOOD MAGNESIUM DECREASED 211 0.0244
211 METABOLIC ACIDOSIS 771 0.0241
212 CORONARY ARTERY STENOSIS 121 0.0240
213 HYPOMAGNESAEMIA 334 0.0240
214 GASTROINTESTINAL HAEMORRHAGE 1996 0.0239
215 DIVERTICULUM INTESTINAL 104 0.0238
216 FULL BLOOD COUNT ABNORMAL 251 0.0237
217 TENSION HEADACHE 102 0.0237
218 HAEMATOMA 606 0.0234
219 CARDIAC PACEMAKER INSERTION 139 0.0233
220 SUBDURAL HAEMATOMA 332 0.0232
221 COAGULOPATHY 386 0.0231
222 HAEMOPTYSIS 645 0.0231
223 DUODENAL ULCER 163 0.0231
224 HIDRADENITIS 210 0.0230
225 HYPOTHYROIDISM 733 0.0229
226 NEPHROPATHY 214 0.0229
227 LACTIC ACIDOSIS 742 0.0229
228 PRE-EXISTING CONDITION IMPROVED 143 0.0229
229 HYPOXIA 806 0.0229
230 ERYSIPELAS 115 0.0229
231 MULTIPLE INJURIES 144 0.0228
232 SPLENOMEGALY 267 0.0228
233 SKIN ABRASION 107 0.0226
234 STAPHYLOCOCCAL SEPSIS 111 0.0225
235 BENIGN PROSTATIC HYPERPLASIA 116 0.0224
236 SUDDEN DEATH 237 0.0224
237 GLUCOSE TOLERANCE IMPAIRED 132 0.0223
238 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1161 0.0222
239 RENAL TUBULAR NECROSIS 217 0.0221
240 ARRHYTHMIA 1046 0.0221
241 MYOCARDIAL ISCHAEMIA 251 0.0220
242 EPISTAXIS 1642 0.0219
243 ARTERIOSCLEROSIS 205 0.0218
244 TOXIC EPIDERMAL NECROLYSIS 330 0.0217
245 HYPERBILIRUBINAEMIA 225 0.0217
246 ECONOMIC PROBLEM 329 0.0217
247 HAEMATEMESIS 548 0.0216
248 RENAL FUNCTION TEST ABNORMAL 100 0.0215
249 RENAL CYST 171 0.0215
250 ECCHYMOSIS 147 0.0214
251 RENAL DISORDER 996 0.0214
252 SYNCOPE 2128 0.0212
253 ACUTE MYOCARDIAL INFARCTION 624 0.0211
254 EOSINOPHIL COUNT INCREASED 175 0.0210
255 MULTI-ORGAN FAILURE 362 0.0209
256 PRESYNCOPE 508 0.0209
257 HAEMODYNAMIC INSTABILITY 159 0.0208
258 SUPRAVENTRICULAR TACHYCARDIA 199 0.0208
259 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 353 0.0208
260 ENCEPHALOPATHY 510 0.0207
261 CORONARY ARTERY DISEASE 628 0.0207
262 DEVICE RELATED INFECTION 319 0.0207
263 EOSINOPHILIA 362 0.0206
264 MALNUTRITION 231 0.0206
265 BLOOD PRESSURE INADEQUATELY CONTROLLED 124 0.0206
266 ANAEMIA 3929 0.0206
267 PRODUCTIVE COUGH 977 0.0204
268 HYPERTHYROIDISM 294 0.0203
269 BLOOD ALKALINE PHOSPHATASE INCREASED 502 0.0202
270 PERIPHERAL VASCULAR DISORDER 104 0.0202
271 HEART RATE DECREASED 708 0.0201
272 CELLULITIS 1012 0.0201
273 CIRCULATORY COLLAPSE 342 0.0201
274 JAUNDICE 540 0.0200
275 DIVERTICULUM 141 0.0198
276 HAEMATOCRIT DECREASED 393 0.0198
277 LYMPHOEDEMA 137 0.0198
278 GAMMA-GLUTAMYLTRANSFERASE INCREASED 438 0.0197
279 VARICOSE VEIN 102 0.0197
280 ANGINA PECTORIS 561 0.0196
281 DYSPNOEA 11078 0.0196
282 BLOOD PRESSURE ABNORMAL 389 0.0195
283 HEART RATE ABNORMAL 109 0.0195
284 HEPATITIS CHOLESTATIC 117 0.0194
285 RENAL INJURY 575 0.0193
286 TACHYPNOEA 261 0.0192
287 INFARCTION 131 0.0191
288 AGRANULOCYTOSIS 354 0.0190
289 ISCHAEMIC STROKE 339 0.0190
290 HEART RATE IRREGULAR 428 0.0189
291 INABILITY TO AFFORD MEDICATION 187 0.0188
292 DECUBITUS ULCER 153 0.0188
293 RESPIRATORY FAILURE 1369 0.0188
294 CLOSTRIDIUM DIFFICILE COLITIS 199 0.0187
295 INTESTINAL ISCHAEMIA 103 0.0187
296 LUNG INFILTRATION 165 0.0187
297 CARDIAC FLUTTER 120 0.0185
298 BREAST PAIN 197 0.0185
299 INTERNAL HAEMORRHAGE 210 0.0184
300 UROSEPSIS 169 0.0183
301 GASTROENTERITIS 267 0.0183
302 GENERAL PHYSICAL HEALTH DETERIORATION 2114 0.0183
303 TOXIC SKIN ERUPTION 184 0.0183
304 CORONARY ARTERY OCCLUSION 250 0.0182
305 RHABDOMYOLYSIS 759 0.0182
306 TUBULOINTERSTITIAL NEPHRITIS 341 0.0182
307 HYPOGLYCAEMIA 882 0.0182
308 CYANOSIS 285 0.0181
309 CARDIAC DISORDER 1694 0.0181
310 SEPTIC SHOCK 785 0.0180
311 HAEMATURIA 615 0.0179
312 DERMATITIS BULLOUS 130 0.0179
313 INGUINAL HERNIA 109 0.0179
314 HYPOCALCAEMIA 339 0.0179
315 EXTRASYSTOLES 125 0.0179
316 FIBROMYALGIA 435 0.0179
317 GASTRIC ULCER 339 0.0178
318 GASTROOESOPHAGEAL REFLUX DISEASE 1435 0.0178
319 PULMONARY MASS 265 0.0178
320 HIATUS HERNIA 230 0.0177
321 HAEMOGLOBIN DECREASED 1814 0.0176
322 HAEMODIALYSIS 148 0.0176
323 HYPOPHOSPHATAEMIA 130 0.0176
324 RESPIRATORY DISTRESS 485 0.0176
325 BREAST MASS 118 0.0176
326 BREAST TENDERNESS 132 0.0175
327 GASTRITIS 460 0.0175
328 SKIN ULCER 450 0.0174
329 FACIAL PAIN 154 0.0172
330 PRODUCT PRESCRIBING ERROR 408 0.0171
331 BACTERAEMIA 203 0.0171
332 NEPHROTIC SYNDROME 117 0.0171
333 HYPOPHAGIA 434 0.0170
334 LIVER DISORDER 750 0.0169
335 ABDOMINAL DISTENSION 1763 0.0169
336 HEPATIC FUNCTION ABNORMAL 629 0.0168
337 SHOCK 387 0.0168
338 POOR QUALITY SLEEP 361 0.0168
339 OBESITY 267 0.0167
340 SKIN LACERATION 182 0.0167
341 CARDIAC ARREST 1380 0.0167
342 BLOOD IRON DECREASED 197 0.0166
343 URINARY RETENTION 553 0.0166
344 ACUTE CORONARY SYNDROME 137 0.0165
345 PERIPHERAL SWELLING 2543 0.0165
346 CARDIO-RESPIRATORY ARREST 689 0.0165
347 EMPHYSEMA 166 0.0164
348 RESPIRATORY RATE INCREASED 146 0.0164
349 PERIPHERAL COLDNESS 225 0.0164
350 RESPIRATORY TRACT INFECTION 425 0.0163
351 LARGE INTESTINE POLYP 113 0.0163
352 AORTIC ANEURYSM 124 0.0163
353 HYPERGLYCAEMIA 593 0.0163
354 MULTIPLE ORGAN DYSFUNCTION SYNDROME 458 0.0162
355 FALL 5362 0.0161
356 RECTAL HAEMORRHAGE 692 0.0161
357 RESPIRATORY SYNCYTIAL VIRUS INFECTION 140 0.0161
358 ASPHYXIA 130 0.0159
359 FLANK PAIN 149 0.0159
360 VASCULITIS 185 0.0159
361 CHEST PAIN 2941 0.0159
362 COUGH 4439 0.0158
363 SPINAL OSTEOARTHRITIS 139 0.0158
364 INSURANCE ISSUE 241 0.0157
365 ASPARTATE AMINOTRANSFERASE INCREASED 837 0.0157
366 ALTERED STATE OF CONSCIOUSNESS 337 0.0155
367 GYNAECOMASTIA 480 0.0155
368 SEPSIS 1724 0.0154
369 HAEMORRHOIDS 299 0.0153
370 HEAD INJURY 485 0.0153
371 DIABETES MELLITUS INADEQUATE CONTROL 271 0.0153
372 BLOOD PRESSURE FLUCTUATION 365 0.0152
373 IMPAIRED GASTRIC EMPTYING 207 0.0152
374 MENTAL STATUS CHANGES 421 0.0151
375 ASPIRATION 166 0.0151
376 ELECTROCARDIOGRAM QT PROLONGED 545 0.0151
377 POST PROCEDURAL HAEMORRHAGE 176 0.0151
378 DEVICE OCCLUSION 212 0.0150
379 PROTEINURIA 286 0.0150
380 ADRENAL INSUFFICIENCY 182 0.0150
381 RESPIRATION ABNORMAL 103 0.0149
382 VITAMIN D DEFICIENCY 145 0.0149
383 WHEEZING 881 0.0148
384 LIVER FUNCTION TEST ABNORMAL 432 0.0148
385 PNEUMONIA ASPIRATION 371 0.0148
386 CHOLELITHIASIS 485 0.0148
387 ULCER HAEMORRHAGE 100 0.0148
388 HAEMORRHAGIC STROKE 115 0.0147
389 FAECES DISCOLOURED 319 0.0147
390 BRONCHITIS 1084 0.0146
391 MYOPATHY 126 0.0146
392 PALPITATIONS 1708 0.0146
393 CEREBRAL INFARCTION 356 0.0146
394 RASH MACULO-PAPULAR 324 0.0145
395 DISSEMINATED INTRAVASCULAR COAGULATION 205 0.0145
396 SPUTUM DISCOLOURED 138 0.0145
397 CONFUSIONAL STATE 2339 0.0145
398 INCREASED TENDENCY TO BRUISE 133 0.0144
399 RIB FRACTURE 297 0.0144
400 PNEUMONIA 4666 0.0144
401 LIPASE INCREASED 110 0.0143
402 CHOLECYSTITIS 171 0.0143
403 URINARY TRACT INFECTION 2446 0.0143
404 BLOOD PRESSURE SYSTOLIC INCREASED 279 0.0143
405 NOCTURIA 173 0.0142
406 DECREASED APPETITE 3310 0.0142
407 MOUTH HAEMORRHAGE 104 0.0142
408 PETECHIAE 147 0.0141
409 ASTHENIA 5282 0.0140
410 BODY TEMPERATURE DECREASED 138 0.0140
411 DECREASED ACTIVITY 151 0.0140
412 THIRST 250 0.0140
413 WEIGHT DECREASED 3897 0.0139
414 PULMONARY HAEMORRHAGE 109 0.0139
415 LEUKOCYTOSIS 252 0.0139
416 HYPOTONIA 139 0.0139
417 MYOCLONUS 166 0.0139
418 OESOPHAGITIS 152 0.0139
419 INCONTINENCE 147 0.0139
420 RED BLOOD CELL COUNT DECREASED 396 0.0138
421 PLATELET COUNT DECREASED 1475 0.0138
422 PNEUMONIA BACTERIAL 127 0.0138
423 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 107 0.0138
424 ORAL CANDIDIASIS 181 0.0137
425 NASAL CONGESTION 805 0.0137
426 C-REACTIVE PROTEIN INCREASED 498 0.0137
427 ARTERIAL OCCLUSIVE DISEASE 107 0.0136
428 HEPATIC STEATOSIS 253 0.0136
429 LUNG DISORDER 662 0.0135
430 LETHARGY 774 0.0134
431 ANAL INCONTINENCE 121 0.0134
432 HYPOKINESIA 195 0.0134
433 HEPATITIS C 162 0.0134
434 STEVENS-JOHNSON SYNDROME 298 0.0134
435 HYPERTENSION 2839 0.0134
436 TYPE 2 DIABETES MELLITUS 451 0.0134
437 CHOLESTASIS 257 0.0134
438 CARDIAC OPERATION 115 0.0134
439 DIZZINESS 6673 0.0134
440 WEIGHT INCREASED 2994 0.0134
441 APNOEA 104 0.0133
442 HEART RATE INCREASED 1323 0.0133
443 ANOREXIA 172 0.0133
444 SINUS TACHYCARDIA 189 0.0133
445 ALANINE AMINOTRANSFERASE INCREASED 817 0.0133
446 PSEUDOMONAS INFECTION 114 0.0133
447 CONTUSION 1275 0.0132
448 HYPOTHERMIA 134 0.0132
449 DYSURIA 487 0.0132
450 DISORIENTATION 523 0.0132
451 DRY THROAT 134 0.0132
452 BLOOD THYROID STIMULATING HORMONE INCREASED 121 0.0131
453 PARKINSONISM 128 0.0131
454 HEPATOCELLULAR INJURY 186 0.0131
455 PALLOR 357 0.0131
456 DELIRIUM 454 0.0131
457 INTERSTITIAL LUNG DISEASE 632 0.0130
458 WHITE BLOOD CELL COUNT INCREASED 499 0.0130
459 LOSS OF CONSCIOUSNESS 1662 0.0130
460 HOSPICE CARE 128 0.0129
461 SINUS CONGESTION 175 0.0129
462 POLLAKIURIA 540 0.0129
463 GALLBLADDER DISORDER 231 0.0129
464 CHEST DISCOMFORT 1322 0.0129
465 TACHYCARDIA 1146 0.0129
466 THERAPY NON-RESPONDER 578 0.0128
467 DIVERTICULITIS 356 0.0128
468 CHOKING 250 0.0128
469 HYPERCALCAEMIA 158 0.0128
470 BLOOD COUNT ABNORMAL 194 0.0128
471 PRESCRIBED UNDERDOSE 255 0.0128
472 CONTRAINDICATED PRODUCT ADMINISTERED 387 0.0128
473 RESPIRATORY TRACT CONGESTION 203 0.0128
474 MUSCULOSKELETAL CHEST PAIN 197 0.0127
475 BLOOD CALCIUM DECREASED 143 0.0127
476 PELVIC FRACTURE 99 0.0127
477 PERITONITIS BACTERIAL 128 0.0127
478 PANCREATITIS ACUTE 285 0.0127
479 URINARY INCONTINENCE 375 0.0126
480 CLOSTRIDIUM DIFFICILE INFECTION 276 0.0126
481 ESCHERICHIA INFECTION 104 0.0126
482 RETCHING 269 0.0126
483 LIMB INJURY 341 0.0125
484 WRIST FRACTURE 150 0.0125
485 HEMIPLEGIA 104 0.0125
486 TRANSIENT ISCHAEMIC ATTACK 420 0.0124
487 STAPHYLOCOCCAL INFECTION 410 0.0124
488 DIARRHOEA 8003 0.0124
489 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 595 0.0124
490 DEPRESSED LEVEL OF CONSCIOUSNESS 490 0.0124
491 COVID-19 PNEUMONIA 146 0.0124
492 MOTOR DYSFUNCTION 126 0.0124
493 LOCALISED INFECTION 299 0.0124
494 DRUG ERUPTION 219 0.0123
495 DRUG LEVEL INCREASED 203 0.0123
496 BRAIN FOG 192 0.0122
497 IMPAIRED QUALITY OF LIFE 176 0.0122
498 SPINAL COMPRESSION FRACTURE 101 0.0122
499 SWELLING 1141 0.0122
500 PANCYTOPENIA 681 0.0122
501 MUSCLE ATROPHY 154 0.0121
502 INITIAL INSOMNIA 124 0.0121
503 GASTRIC HAEMORRHAGE 139 0.0121
504 BODY HEIGHT DECREASED 129 0.0121
505 CONDITION AGGRAVATED 3655 0.0120
506 GINGIVAL BLEEDING 164 0.0120
507 TENDERNESS 125 0.0120
508 MUSCULAR WEAKNESS 1362 0.0120
509 KIDNEY INFECTION 235 0.0120
510 UPPER RESPIRATORY TRACT INFECTION 552 0.0119
511 MUSCLE STRAIN 103 0.0119
512 THROMBOCYTOPENIA 1330 0.0119
513 PYELONEPHRITIS 103 0.0119
514 FEEDING DISORDER 241 0.0119
515 SLUGGISHNESS 121 0.0119
516 PNEUMOTHORAX 188 0.0118
517 GASTROENTERITIS VIRAL 214 0.0118
518 ACUTE RESPIRATORY DISTRESS SYNDROME 209 0.0118
519 TREATMENT NONCOMPLIANCE 646 0.0118
520 TOOTH INFECTION 155 0.0117
521 THROAT IRRITATION 527 0.0117
522 MYOSITIS 105 0.0117
523 DIALYSIS 166 0.0117
524 CONSTIPATION 2551 0.0117
525 SINUS DISORDER 231 0.0117
526 ABDOMINAL PAIN 2708 0.0116
527 BLOOD CALCIUM INCREASED 102 0.0116
528 BLOOD PRESSURE INCREASED 1774 0.0116
529 ROTATOR CUFF SYNDROME 149 0.0116
530 DIABETES MELLITUS 880 0.0115
531 HAEMATOCHEZIA 637 0.0115
532 CEREBRAL HAEMORRHAGE 413 0.0115
533 LIGAMENT SPRAIN 114 0.0115
534 BLOOD GLUCOSE FLUCTUATION 126 0.0115
535 FACE OEDEMA 193 0.0114
536 UNRESPONSIVE TO STIMULI 293 0.0113
537 VIRAL INFECTION 377 0.0113
538 DEEP VEIN THROMBOSIS 736 0.0113
539 NEURALGIA 275 0.0113
540 MYOCARDITIS 129 0.0112
541 FATIGUE 8762 0.0112
542 GLYCOSYLATED HAEMOGLOBIN INCREASED 282 0.0112
543 LACERATION 105 0.0112
544 DEMENTIA 312 0.0112
545 TEMPERATURE INTOLERANCE 115 0.0111
546 POLYNEUROPATHY 133 0.0111
547 HEMIPARESIS 188 0.0111
548 MIDDLE INSOMNIA 207 0.0111
549 RESPIRATORY DISORDER 331 0.0111
550 HALLUCINATION, VISUAL 233 0.0110
551 CYSTITIS 351 0.0110
552 MUSCLE TWITCHING 253 0.0110
553 RESTLESS LEGS SYNDROME 199 0.0109
554 VOMITING 5144 0.0109
555 GASTROINTESTINAL INFECTION 98 0.0109
556 MUSCULOSKELETAL DISCOMFORT 188 0.0109
557 RHINORRHOEA 706 0.0109
558 INTERVERTEBRAL DISC DEGENERATION 101 0.0109
559 SCIATICA 174 0.0109
560 HYPERSOMNIA 312 0.0109
561 COMPLICATION ASSOCIATED WITH DEVICE 157 0.0108
562 BACK PAIN 2511 0.0108
563 BLOOD CREATINE PHOSPHOKINASE INCREASED 311 0.0108
564 ASTHMA 1221 0.0108
565 POST PROCEDURAL COMPLICATION 207 0.0108
566 INTENTIONAL DOSE OMISSION 307 0.0108
567 CHROMATURIA 243 0.0108
568 OSTEOPOROSIS 442 0.0107
569 BLOOD LACTATE DEHYDROGENASE INCREASED 170 0.0107
570 FLUSHING 1089 0.0107
571 FEELING COLD 298 0.0107
572 BACTERIAL INFECTION 199 0.0107
573 MYOCARDIAL INFARCTION 1859 0.0106
574 OSTEOPENIA 161 0.0106
575 BLOOD TRIGLYCERIDES INCREASED 187 0.0106
576 HYPERCHOLESTEROLAEMIA 102 0.0106
577 MALAISE 4632 0.0106
578 NAUSEA 8345 0.0105
579 OSTEOARTHRITIS 446 0.0105
580 SMALL INTESTINAL OBSTRUCTION 129 0.0105
581 PULMONARY FIBROSIS 201 0.0105
582 MUSCLE SPASMS 1919 0.0104
583 PULMONARY THROMBOSIS 114 0.0104
584 FLATULENCE 592 0.0104
585 FULL BLOOD COUNT DECREASED 210 0.0104
586 DRUG-INDUCED LIVER INJURY 326 0.0104
587 THERAPY PARTIAL RESPONDER 162 0.0104
588 DYSPHONIA 605 0.0103
589 CANDIDA INFECTION 174 0.0103
590 LYMPHOCYTE COUNT DECREASED 182 0.0103
591 PHOTOSENSITIVITY REACTION 170 0.0103
592 ANHEDONIA 270 0.0103
593 BALANCE DISORDER 887 0.0103
594 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 264 0.0102
595 JOINT INJURY 219 0.0102
596 HYPERTENSIVE CRISIS 114 0.0102
597 PAIN IN EXTREMITY 3015 0.0102
598 HEADACHE 6414 0.0102
599 WOUND INFECTION 112 0.0102
600 ABSCESS 163 0.0102
601 SKIN HAEMORRHAGE 151 0.0102
602 PULMONARY EMBOLISM 967 0.0102
603 SKIN DISORDER 339 0.0102
604 SKIN INFECTION 114 0.0102
605 GAIT DISTURBANCE 1940 0.0101
606 JOINT DISLOCATION 107 0.0101
607 RENAL PAIN 107 0.0101
608 SINUSITIS 1031 0.0100
609 SCRATCH 106 0.0100
610 EAR DISCOMFORT 103 0.0100
611 BURNING SENSATION 703 0.0100
612 ABDOMINAL PAIN UPPER 2061 0.0100
613 PRODUCT ADMINISTRATION ERROR 202 0.0100
614 DYSPEPSIA 983 0.0100
615 THYROID DISORDER 154 0.0100
616 PARALYSIS 143 0.0100
617 NECK PAIN 558 0.0100
618 HAIR COLOUR CHANGES 124 0.0100
619 ANKLE FRACTURE 154 0.0099
620 DYSARTHRIA 374 0.0099
621 HAEMORRHAGE INTRACRANIAL 148 0.0099
622 ACUTE HEPATIC FAILURE 135 0.0099
623 POOR VENOUS ACCESS 102 0.0098
624 OROPHARYNGEAL PAIN 912 0.0098
625 CYST 122 0.0098
626 ORAL PAIN 220 0.0098
627 TOOTH ABSCESS 100 0.0098
628 LUNG INFECTION 152 0.0098
629 SKIN DISCOLOURATION 449 0.0098
630 HEPATITIS 250 0.0098
631 VERTIGO 595 0.0098
632 SCAR 167 0.0097
633 BLOOD URINE PRESENT 185 0.0097
634 SARS-COV-2 TEST POSITIVE 128 0.0097
635 LABORATORY TEST ABNORMAL 286 0.0097
636 DRUG PRESCRIBING ERROR 186 0.0097
637 COLON CANCER 144 0.0097
638 UNEVALUABLE EVENT 731 0.0097
639 DISEASE PROGRESSION 1143 0.0097
640 EYE INFECTION 109 0.0096
641 SPINAL PAIN 113 0.0096
642 MUSCLE TIGHTNESS 156 0.0096
643 TOOTHACHE 174 0.0096
644 MUSCULOSKELETAL PAIN 503 0.0096
645 PLATELET COUNT INCREASED 125 0.0096
646 EATING DISORDER 204 0.0096
647 INTERVERTEBRAL DISC PROTRUSION 209 0.0096
648 BODY TEMPERATURE INCREASED 195 0.0095
649 HEAD DISCOMFORT 169 0.0095
650 CATARACT 567 0.0095
651 SKIN LESION 261 0.0095
652 TASTE DISORDER 193 0.0095
653 SOMNOLENCE 1913 0.0095
654 PARAESTHESIA ORAL 137 0.0095
655 HIP FRACTURE 305 0.0095
656 WOUND 265 0.0095
657 DYSPHAGIA 899 0.0095
658 DRY MOUTH 766 0.0094
659 HAEMORRHAGE 986 0.0094
660 INFLUENZA 1050 0.0094
661 BLOOD GLUCOSE DECREASED 452 0.0094
662 COLD SWEAT 165 0.0094
663 ILLNESS 964 0.0093
664 NEPHROPATHY TOXIC 105 0.0093
665 TRANSAMINASES INCREASED 207 0.0093
666 INFLAMMATION 480 0.0093
667 MYALGIA 1580 0.0093
668 MUSCLE RIGIDITY 111 0.0093
669 FEAR 248 0.0092
670 FUNGAL INFECTION 307 0.0092
671 HERNIA 178 0.0092
672 ULCER 146 0.0092
673 DIPLOPIA 238 0.0092
674 SPEECH DISORDER 480 0.0092
675 LIMB DISCOMFORT 283 0.0091
676 DENTAL CARIES 101 0.0091
677 BACK DISORDER 148 0.0091
678 ABDOMINAL DISCOMFORT 1521 0.0091
679 DEVICE FAILURE 138 0.0091
680 PYREXIA 3130 0.0090
681 APHASIA 273 0.0090
682 BACK INJURY 98 0.0090
683 TINNITUS 414 0.0090
684 NEPHROLITHIASIS 413 0.0090
685 GASTROINTESTINAL PAIN 99 0.0090
686 SPINAL FRACTURE 180 0.0090
687 SNEEZING 201 0.0090
688 COGNITIVE DISORDER 418 0.0089
689 SECRETION DISCHARGE 112 0.0089
690 FEELING ABNORMAL 2142 0.0089
691 ILEUS 111 0.0089
692 MICTURITION URGENCY 102 0.0089
693 CHOLECYSTECTOMY 102 0.0089
694 ORAL HERPES 174 0.0089
695 OSTEOMYELITIS 161 0.0089
696 MEMORY IMPAIRMENT 1220 0.0089
697 PANCREATITIS 469 0.0089
698 AMNESIA 577 0.0089
699 PHARYNGITIS 110 0.0089
700 LIP SWELLING 295 0.0088
701 ABDOMINAL PAIN LOWER 223 0.0088
702 PERICARDITIS 148 0.0088
703 DYSSTASIA 257 0.0088
704 BRONCHOSPASM 125 0.0088
705 LYMPHADENOPATHY 310 0.0087
706 EAR PAIN 170 0.0087
707 INFECTION 1261 0.0087
708 INSOMNIA 2320 0.0087
709 COVID-19 1522 0.0087
710 BLISTER 487 0.0087
711 DEVICE DISLOCATION 377 0.0087
712 BLOOD GLUCOSE INCREASED 1632 0.0087
713 ANGIOEDEMA 383 0.0086
714 HYPERHIDROSIS 1115 0.0086
715 THROMBOSIS 695 0.0086
716 EYE HAEMORRHAGE 115 0.0086
717 ERUCTATION 166 0.0086
718 TREMOR 1418 0.0085
719 ARTHRITIS 670 0.0085
720 THERAPY INTERRUPTED 608 0.0085
721 GAIT INABILITY 284 0.0085
722 QUALITY OF LIFE DECREASED 114 0.0085
723 HERPES ZOSTER 488 0.0085
724 BEDRIDDEN 111 0.0084
725 NEUROPATHY PERIPHERAL 803 0.0084
726 UPPER LIMB FRACTURE 168 0.0084
727 ANOSMIA 122 0.0084
728 BASAL CELL CARCINOMA 131 0.0084
729 DRUG INTOLERANCE 810 0.0084
730 LIVER FUNCTION TEST INCREASED 180 0.0084
731 NODULE 109 0.0083
732 RASH PAPULAR 187 0.0083
733 COLITIS 316 0.0083
734 SLEEP DISORDER 588 0.0083
735 APHONIA 116 0.0083
736 DISTURBANCE IN ATTENTION 448 0.0083
737 NASOPHARYNGITIS 1528 0.0083
738 FOOT FRACTURE 157 0.0083
739 PRURITUS GENERALISED 179 0.0083
740 ARTHRALGIA 3432 0.0082
741 HALLUCINATION 622 0.0082
742 METASTASES TO LIVER 145 0.0082
743 INTENTIONAL PRODUCT USE ISSUE 721 0.0082
744 ANXIETY 2342 0.0082
745 HOSPITALISATION 1264 0.0082
746 MIGRAINE 785 0.0082
747 RASH MACULAR 287 0.0082
748 PROSTATIC SPECIFIC ANTIGEN INCREASED 113 0.0082
749 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 191 0.0082
750 CONJUNCTIVITIS 152 0.0082
751 DERMATITIS ALLERGIC 103 0.0082
752 JOINT SWELLING 984 0.0081
753 MOBILITY DECREASED 584 0.0081
754 CHILLS 951 0.0081
755 PRURITUS 3115 0.0081
756 TOOTH DISORDER 180 0.0081
757 MYELODYSPLASTIC SYNDROME 117 0.0081
758 HEPATIC CYTOLYSIS 103 0.0081
759 FEELING HOT 495 0.0081
760 INJURY 566 0.0080
761 BONE PAIN 471 0.0080
762 IMPAIRED HEALING 263 0.0080
763 HYPOAESTHESIA 1198 0.0080
764 HOT FLUSH 602 0.0080
765 SKIN FISSURES 156 0.0080
766 COMA 380 0.0080
767 BLOOD GLUCOSE ABNORMAL 147 0.0080
768 APATHY 116 0.0079
769 HYPOACUSIS 342 0.0079
770 ACTIVITIES OF DAILY LIVING IMPAIRED 157 0.0079
771 DEPRESSION 1801 0.0079
772 RESPIRATORY ARREST 218 0.0079
773 AGEUSIA 197 0.0079
774 RESTLESSNESS 289 0.0079
775 BONE DISORDER 143 0.0078
776 DEAFNESS 205 0.0078
777 CARDIOVASCULAR DISORDER 199 0.0078
778 GASTROINTESTINAL DISORDER 702 0.0078
779 INTESTINAL OBSTRUCTION 293 0.0078
780 PAIN OF SKIN 209 0.0078
781 NERVOUSNESS 405 0.0077
782 NEUTROPHIL COUNT DECREASED 315 0.0077
783 IMMUNODEFICIENCY 115 0.0077
784 SWELLING FACE 502 0.0077
785 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 548 0.0077
786 HAIR TEXTURE ABNORMAL 103 0.0077
787 LEUKOPENIA 385 0.0077
788 RASH PRURITIC 417 0.0077
789 EYE PAIN 434 0.0077
790 WHITE BLOOD CELL COUNT DECREASED 831 0.0077
791 SKIN CANCER 165 0.0077
792 CEREBROVASCULAR ACCIDENT 1296 0.0076
793 PANIC ATTACK 278 0.0076
794 FREQUENT BOWEL MOVEMENTS 206 0.0076
795 IMPAIRED WORK ABILITY 163 0.0076
796 AGITATION 560 0.0076
797 PAIN 4635 0.0075
798 HEPATIC ENZYME INCREASED 511 0.0075
799 STOMATITIS 453 0.0075
800 PRODUCT AVAILABILITY ISSUE 170 0.0075
801 SURGERY 437 0.0074
802 SEROTONIN SYNDROME 143 0.0074
803 BLINDNESS 302 0.0074
804 BLOOD CHOLESTEROL INCREASED 345 0.0074
805 FRACTURE 140 0.0074
806 METASTASES TO BONE 121 0.0074
807 FEELING JITTERY 140 0.0073
808 SWOLLEN TONGUE 229 0.0073
809 IRRITABLE BOWEL SYNDROME 157 0.0073
810 LACRIMATION INCREASED 221 0.0073
811 NIGHT SWEATS 235 0.0073
812 PERITONITIS 151 0.0073
813 VISION BLURRED 995 0.0072
814 EYE PRURITUS 243 0.0072
815 RASH ERYTHEMATOUS 345 0.0072
816 VISUAL IMPAIRMENT 890 0.0072
817 ALOPECIA 1409 0.0072
818 DERMATITIS 150 0.0072
819 LIVER INJURY 175 0.0071
820 DISEASE RECURRENCE 339 0.0071
821 DRY EYE 355 0.0071
822 LOWER RESPIRATORY TRACT INFECTION 323 0.0071
823 PRODUCT DOSE OMISSION IN ERROR 201 0.0071
824 HEPATOTOXICITY 158 0.0071
825 ABASIA 175 0.0071
826 MEDICATION ERROR 392 0.0070
827 THERAPEUTIC RESPONSE UNEXPECTED 316 0.0070
828 FEMUR FRACTURE 218 0.0070
829 LOWER LIMB FRACTURE 135 0.0070
830 DEPRESSED MOOD 370 0.0070
831 OFF LABEL USE 6086 0.0069
832 LOCAL SWELLING 121 0.0069
833 PRODUCT USE ISSUE 1302 0.0069
834 TENDONITIS 107 0.0069
835 ROAD TRAFFIC ACCIDENT 289 0.0069
836 MUCOSAL INFLAMMATION 180 0.0069
837 PHOTOPHOBIA 129 0.0069
838 MOUTH ULCERATION 144 0.0068
839 EYE SWELLING 254 0.0068
840 PRODUCT DOSE OMISSION ISSUE 2007 0.0068
841 DISCOMFORT 415 0.0068
842 EAR INFECTION 181 0.0068
843 CRYING 247 0.0068
844 ECZEMA 355 0.0068
845 MOVEMENT DISORDER 217 0.0068
846 GLAUCOMA 130 0.0067
847 FEBRILE NEUTROPENIA 446 0.0067
848 MENTAL DISORDER 292 0.0067
849 DYSGEUSIA 498 0.0067
850 RASH 2918 0.0067
851 PNEUMONITIS 182 0.0067
852 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1200 0.0067
853 NIGHTMARE 230 0.0066
854 GASTRIC DISORDER 228 0.0066
855 MANIA 108 0.0066
856 SKIN EXFOLIATION 551 0.0065
857 ERYTHEMA 1331 0.0065
858 DRY SKIN 864 0.0065
859 VAGINAL HAEMORRHAGE 280 0.0064
860 PROCEDURAL PAIN 178 0.0064
861 THERAPY CESSATION 329 0.0064
862 SEIZURE 735 0.0064
863 ACCIDENTAL OVERDOSE 232 0.0063
864 ERECTILE DYSFUNCTION 161 0.0063
865 GLOSSODYNIA 140 0.0062
866 MENTAL IMPAIRMENT 151 0.0062
867 PARAESTHESIA 980 0.0062
868 PELVIC PAIN 113 0.0062
869 MULTIPLE FRACTURES 102 0.0062
870 PRESCRIBED OVERDOSE 120 0.0062
871 EYE DISORDER 202 0.0061
872 NEOPLASM PROGRESSION 213 0.0061
873 KNEE ARTHROPLASTY 128 0.0061
874 PRODUCT USE IN UNAPPROVED INDICATION 1503 0.0061
875 DEATH 5212 0.0060
876 PRODUCT SUBSTITUTION ISSUE 346 0.0060
877 NEUTROPENIA 817 0.0060
878 DIABETIC KETOACIDOSIS 144 0.0060
879 SEDATION 157 0.0060
880 INFLUENZA LIKE ILLNESS 490 0.0059
881 THROAT TIGHTNESS 161 0.0059
882 MUSCULOSKELETAL STIFFNESS 521 0.0059
883 JOINT STIFFNESS 155 0.0059
884 DYSKINESIA 240 0.0059
885 THINKING ABNORMAL 110 0.0059
886 DRUG RESISTANCE 151 0.0059
887 RASH GENERALISED 151 0.0058
888 PRODUCT DOSE OMISSION 380 0.0058
889 BONE MARROW FAILURE 118 0.0058
890 TOXICITY TO VARIOUS AGENTS 978 0.0058
891 ANAPHYLACTIC SHOCK 147 0.0057
892 PLASMA CELL MYELOMA 222 0.0057
893 VISUAL ACUITY REDUCED 189 0.0057
894 ARTHROPATHY 315 0.0057
895 INCREASED APPETITE 108 0.0056
896 UNDERDOSE 412 0.0056
897 MALIGNANT NEOPLASM PROGRESSION 578 0.0056
898 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 397 0.0056
899 INFUSION RELATED REACTION 369 0.0056
900 EMOTIONAL DISORDER 171 0.0055
901 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 304 0.0055
902 PRODUCT DISPENSING ERROR 120 0.0055
903 HYPERSENSITIVITY 1022 0.0055
904 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1102 0.0054
905 ILL-DEFINED DISORDER 324 0.0053
906 INTENTIONAL PRODUCT MISUSE 465 0.0053
907 IRRITABILITY 315 0.0052
908 PRODUCT PRESCRIBING ISSUE 114 0.0052
909 BONE DENSITY DECREASED 163 0.0052
910 SYSTEMIC LUPUS ERYTHEMATOSUS 184 0.0052
911 DISABILITY 102 0.0052
912 OCULAR HYPERAEMIA 244 0.0051
913 LUNG NEOPLASM MALIGNANT 211 0.0051
914 URTICARIA 852 0.0051
915 DEVICE MALFUNCTION 355 0.0050
916 DRUG ADMINISTRATION ERROR 154 0.0050
917 CYTOKINE RELEASE SYNDROME 99 0.0049
918 CONVULSION 276 0.0048
919 ANGER 163 0.0048
920 ANAPHYLACTIC REACTION 265 0.0048
921 ADVERSE EVENT 442 0.0048
922 ABNORMAL DREAMS 132 0.0048
923 EPILEPSY 146 0.0048
924 DEVICE LEAKAGE 206 0.0047
925 NERVOUS SYSTEM DISORDER 146 0.0047
926 EYE IRRITATION 267 0.0046
927 ABNORMAL BEHAVIOUR 183 0.0046
928 MOOD SWINGS 147 0.0046
929 MOOD ALTERED 124 0.0045
930 DEVICE ISSUE 404 0.0045
931 ADVERSE DRUG REACTION 404 0.0045
932 EMOTIONAL DISTRESS 539 0.0044
933 INJECTION SITE RASH 135 0.0044
934 HEPATIC CANCER 105 0.0044
935 AGGRESSION 216 0.0043
936 RHEUMATOID ARTHRITIS 484 0.0043
937 DRUG INEFFECTIVE 5550 0.0042
938 THERAPEUTIC RESPONSE DECREASED 255 0.0042
939 PHARMACEUTICAL PRODUCT COMPLAINT 109 0.0042
940 INJECTION SITE PRURITUS 281 0.0042
941 PSORIASIS 544 0.0042
942 SUICIDAL IDEATION 381 0.0042
943 THERAPEUTIC RESPONSE SHORTENED 138 0.0042
944 MENSTRUATION IRREGULAR 110 0.0041
945 NEOPLASM MALIGNANT 274 0.0041
946 INCORRECT DOSE ADMINISTERED 929 0.0041
947 PSYCHOTIC DISORDER 120 0.0041
948 DRUG DOSE OMISSION 669 0.0040
949 DEVICE BREAKAGE 164 0.0040
950 ACNE 303 0.0040
951 WRONG TECHNIQUE IN DRUG USAGE PROCESS 143 0.0039
952 INJECTION SITE BRUISING 311 0.0039
953 PSORIATIC ARTHROPATHY 158 0.0039
954 OVERDOSE 824 0.0038
955 PANCREATIC CARCINOMA 109 0.0038
956 EXTRA DOSE ADMINISTERED 149 0.0037
957 DERMATITIS ATOPIC 190 0.0036
958 DEVICE USE ERROR 125 0.0036
959 NEEDLE ISSUE 104 0.0036
960 INJECTION SITE HAEMORRHAGE 283 0.0035
961 INJECTION SITE MASS 131 0.0035
962 OSTEONECROSIS 116 0.0035
963 SKIN IRRITATION 160 0.0035
964 SUICIDE ATTEMPT 211 0.0035
965 EXPIRED PRODUCT ADMINISTERED 115 0.0035
966 COLITIS ULCERATIVE 154 0.0034
967 INJECTION SITE ERYTHEMA 421 0.0034
968 DRUG EFFECT INCOMPLETE 120 0.0033
969 WITHDRAWAL SYNDROME 138 0.0033
970 TREATMENT FAILURE 271 0.0033
971 THERAPEUTIC PRODUCT EFFECT DECREASED 143 0.0032
972 INJECTION SITE PAIN 974 0.0032
973 PRODUCT QUALITY ISSUE 424 0.0031
974 INJECTION SITE SWELLING 238 0.0031
975 DRUG EFFECT DECREASED 155 0.0029
976 MATERNAL EXPOSURE DURING PREGNANCY 249 0.0028
977 COMPLETED SUICIDE 223 0.0027
978 INTENTIONAL OVERDOSE 170 0.0026
979 INJECTION SITE REACTION 180 0.0026
980 MULTIPLE SCLEROSIS 125 0.0026
981 EXPOSURE DURING PREGNANCY 162 0.0026
982 BREAST CANCER 230 0.0025
983 SKIN BURNING SENSATION 176 0.0025
984 FOETAL EXPOSURE DURING PREGNANCY 184 0.0023
985 NO ADVERSE EVENT 410 0.0023
986 MULTIPLE SCLEROSIS RELAPSE 147 0.0021
987 DEVICE DIFFICULT TO USE 129 0.0019
988 ACCIDENTAL EXPOSURE TO PRODUCT 199 0.0019
989 PROSTATE CANCER 139 0.0017
990 DEVICE EXPULSION 111 0.0017
991 DRUG ABUSE 127 0.0015
992 DRUG WITHDRAWAL SYNDROME 131 0.0015
993 PRODUCT STORAGE ERROR 110 0.0013
994 DRUG DEPENDENCE 170 0.0011